Cargando…

Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes

The relationship between serial changes in soluble tumor necrosis factor receptor type 1 (TNFR1) levels and an early decline in estimated glomerular filtration rate (eGFR) decline remains to be defined. We found that in patients with an early decline in renal function (n = 30), soluble TNFR1 values...

Descripción completa

Detalles Bibliográficos
Autores principales: MacIsaac, Richard J, Farag, Matthew, Obeyesekere, Varuni, Clarke, Michele, Boston, Ray, Ward, Glenn M, Jerums, George, Ekinci, Elif I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825941/
https://www.ncbi.nlm.nih.gov/pubmed/30989829
http://dx.doi.org/10.1111/jdi.13061
_version_ 1783464981808807936
author MacIsaac, Richard J
Farag, Matthew
Obeyesekere, Varuni
Clarke, Michele
Boston, Ray
Ward, Glenn M
Jerums, George
Ekinci, Elif I
author_facet MacIsaac, Richard J
Farag, Matthew
Obeyesekere, Varuni
Clarke, Michele
Boston, Ray
Ward, Glenn M
Jerums, George
Ekinci, Elif I
author_sort MacIsaac, Richard J
collection PubMed
description The relationship between serial changes in soluble tumor necrosis factor receptor type 1 (TNFR1) levels and an early decline in estimated glomerular filtration rate (eGFR) decline remains to be defined. We found that in patients with an early decline in renal function (n = 30), soluble TNFR1 values increased (2,595 ± 683 vs 3,596 ± 1,203 pg/mL, P < 0.001) as eGFR decreased (89 ± 1 vs 51 ± 2 mL/min/1.73m(2), P < 0.001) over an 8‐year period. In contrast, there were no significant changes in soluble TNFR1 levels in patients with stable renal function (n = 17). In a multilevel mixed effects regression model, changes in soluble TNFR1 levels were found to be independently associated with eGFR decline (Z = −4.31, P < 0.001). An early decline in eGFR is associated with an increase in soluble TNFR levels; however, the factors driving this increase and the possible pathological role that soluble TNFR1 plays in progressive diabetic kidney disease remain to be determined.
format Online
Article
Text
id pubmed-6825941
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68259412019-11-07 Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes MacIsaac, Richard J Farag, Matthew Obeyesekere, Varuni Clarke, Michele Boston, Ray Ward, Glenn M Jerums, George Ekinci, Elif I J Diabetes Investig Articles The relationship between serial changes in soluble tumor necrosis factor receptor type 1 (TNFR1) levels and an early decline in estimated glomerular filtration rate (eGFR) decline remains to be defined. We found that in patients with an early decline in renal function (n = 30), soluble TNFR1 values increased (2,595 ± 683 vs 3,596 ± 1,203 pg/mL, P < 0.001) as eGFR decreased (89 ± 1 vs 51 ± 2 mL/min/1.73m(2), P < 0.001) over an 8‐year period. In contrast, there were no significant changes in soluble TNFR1 levels in patients with stable renal function (n = 17). In a multilevel mixed effects regression model, changes in soluble TNFR1 levels were found to be independently associated with eGFR decline (Z = −4.31, P < 0.001). An early decline in eGFR is associated with an increase in soluble TNFR levels; however, the factors driving this increase and the possible pathological role that soluble TNFR1 plays in progressive diabetic kidney disease remain to be determined. John Wiley and Sons Inc. 2019-06-03 2019-11 /pmc/articles/PMC6825941/ /pubmed/30989829 http://dx.doi.org/10.1111/jdi.13061 Text en © 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
MacIsaac, Richard J
Farag, Matthew
Obeyesekere, Varuni
Clarke, Michele
Boston, Ray
Ward, Glenn M
Jerums, George
Ekinci, Elif I
Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes
title Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes
title_full Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes
title_fullStr Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes
title_full_unstemmed Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes
title_short Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes
title_sort changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825941/
https://www.ncbi.nlm.nih.gov/pubmed/30989829
http://dx.doi.org/10.1111/jdi.13061
work_keys_str_mv AT macisaacrichardj changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes
AT faragmatthew changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes
AT obeyesekerevaruni changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes
AT clarkemichele changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes
AT bostonray changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes
AT wardglennm changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes
AT jerumsgeorge changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes
AT ekincielifi changesinsolubletumornecrosisfactorreceptortype1levelsandearlyrenalfunctiondeclineinpatientswithdiabetes